CBI provides a range of pharmacology capabilities across a spectrum of indications that ensure reliable results in the drug-discovery process. Assessment and analysis modalities are fine-tuned to meet the specific requirements demanded in each targeted area of scientific investigation.

Ocular Pharmacology
Cardiovascular Pharmacology
Inflammation Pharmacology
Anti-infective Studies
Oncology and Xenograft Studies
Stem Cell and Nanoparticle Pharmacology

All Comparative Biosciences Inc. Pharmacology Studies Include:

  • Experienced, highly trained study directors
  • Complete and comprehensive documentation
  • High quality reports
  • Rapid report preparation
  • All pathology performed by a board-certified pathologist
  • All clinical chemistry reviewed and interpreted by a board-certified pathologist

Ocular Modeling and Pharmacology
Ocular in vivo modeling

One of our newest areas of expertise, CBI offers discovery and development pharmacology studies for ocular indications.

  • Retinopathy of Prematurity Model in infant mice and rats
  • Laser-induced retinal neovascularization (macular degeneration) in rats and rabbits
  • Corneal pockets in rats and rabbits for neovascularization
  • Intra-ocular implants
  • Ocular inflammation
  • Ocular pharmacokinetics and toxicology
  • Ocular toxicity or tolerability studies
  • Corneal vascularization
  • Corneal injury models

Cardiovascular Pharmacology
Cardiovascular in vivo modeling

  • Myocardial ischemia and reperfusion
  • Aortic banding for chronic congestive heart failure
  • Atherosclerosis in ApoE mice, hamsters, guinea pigs, Watanabe rabbits and pigs
  • Balloon angioplasty in rats and rabbits
  • Stent placement in rats and rabbits
  • Stem cell capabilities
  • More information on cardiovascular studies

Inflammation Pharmacology
Inflammation in vivo modeling

  • Local irritation and tolerability
  • Inflammation- acute, chronic
  • Inflammation-LPS-induced, DTH, TNBF, CNBF
  • Arthritis—Collagen, adjuvant, antibody, LPS induced
  • Osteoarthritis—Chemically or surgically induced
  • Asthma-ovalbumin induced
  • Colitis—DSS, TNBF, others
  • Psoriasis
  • Diabetes, Fat Metabolism
  • CNS-EAE, meningitis, stroke
  • Ocular inflammation
  • Radiation induced- bone marrow, bladder and colon inflammation

Anti-infective Modeling and Pharmacology

  • Mouse protection test
  • Neutropenic thigh abscess
  • Dermal inflammation and abscessation
  • Bacterial pneumonia
  • Cytodex bead subcutaneous abscess
  • Bacterial endocarditis
  • Sepsis; Clostridium diarrhea
  • ATCC and custom bacterial strains available
  • Mini Tox and Mini PK studies to support efficacy studies

Oncology and Xenograft Studies

  • Numerous cell lines validated
  • Subcutaneous, intravenous and orthotopic implantantion
  • Immunocompromized and immunocompetent rodents, including knockout and transgenics
  • Angiogenesis capabilities
  • Stem cell capabilities
  • Immunohistochemistry and In Situ
  • ATCC and custom tumor cells lines
  • Tumor growth data managed by LABCAT
  • More information on xenograft modeling and cancer research

Stem Cell and Nanoparticle Pharmacology

  • Comparative Biosciences provides experience and capabilities in the new and expanding research areas of stem cells and nanoparticle pharmacology
  • Stem Cell Pharmacology: tumor biology, cardiovascular and CNS applications
  • Nanoparticles: Pharmacokinetics, toxicology and custom pharmacology

All Pharmacology Studies Include

  • Experienced, highly trained study directors
  • Senior staff with extensive experience in pharmacology, surgery and in vivo modeling
  • Complete and comprehensive documentation
  • High quality, rapid reports
  • All pathology performed by board-certified pathologist
  • All clinical chemistry reviewed and interpreted by board-certified pathologist

Top